Pulmonary Arterial Hypertension Diagnosis, Classifications and Therapy
This webcast reviews challenges in the treatment of Pulmonary Arterial Hypertension and CTEPH as well as classification scheme and evolution in diagnostic tests for all types of Pulmonary Hypertension. Traditional and novel endpoints in Pulmonary Arterial Hypertension clinical trials will be discussed as well as assets and deficiencies of short-term vs. long-term PAH clinical trials. The webcast will also review upcoming clinical trials evaluating new targets in PAH. Visit http://www.ccfcme.org/ph16yt to claim CME credit or learn more about the Pulmonary Hypertension Summit series. The video was produced by the Cleveland Clinic Foundation Center for Continuing Education and Respiratory Institute.

▶︎
Pulmonary Vascular Disease

▶︎
Classification, Diagnosis, and Management of Pulmonary Hypertension: Focus on Group 1 Disease

▶︎
Pulmonary Hypertension... A Rare Disease?

▶︎
Pulmonary fibrosis 101 with Dr. Amy Hajari Case

▶︎
Pulmonary Arterial Hypertension: The Diagnosis You Don't Want to Miss

▶︎
: Evaluation of a Patient Suspected to Have Pulmonary Hypertension

▶︎
Women's Health & HHT

▶︎
Group2 Pulmonary Hypertension: Isn't it Just Heart Failure? and Left Ventricle Thrombosis

▶︎
Pulmonary Arterial Hypertension: Addressing Diagnostic and Therapeutic Challenges

▶︎
Journey through Pulmonary Hypertension Diagnosis and Treatment

▶︎
Friday Session 3: HFpEF and Pulmonary Hypertension

▶︎
Webcast: Florida Viral Hepatitis Network: Hepatitis Elimination Series Part 2

▶︎
Pulmonary Artery Hypertension | Clinical Medicine

▶︎
Pulmonary Hypertension: The Future is Now

▶︎
Pulmonary Hypertension: Review of Diagnosis and Treatment

▶︎
PF Medications Explained: What to expect, and benefits & risks

▶︎
The Echo in PAH: Pathophysiology of the Right Heart and Treatment Goals in PAH

▶︎
Pulmonary Arterial Hypertension in Systemic Sclerosis- Dinesh Khanna, MD, MS- 2019 National Conf.

▶︎
Management of Group 2 Pulmonary Hypertension: Hope or Hype (Raymond L. Benza, MD) February 17, 2022

▶︎
